OcyonBio and Biosimilar Solutions announce agreement to create a contract biosimilars development/manufacturing organisation

Mar 14, 2022

OcyonBio announced that it has entered into a manufacturing and operations agreement with Biosimilar Solutions Inc. to create a contract biosimilars development/manufacturing organisation (including process development, plasmid, vectors, cell banks, processing and testing facilities) in Puerto Rico.  Biosimilar Solutions expects to manufacture recombinant proteins and monoclonal antibodies from 2022.